Epigenetic control of nuclear architecture.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 2771143)

Published in Cell Mol Life Sci on February 01, 2007

Authors

J Espada1, M Esteller

Author Affiliations

1: Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain. mesteller@cnio.es

Articles citing this

Organ and gestational age effects of maternal nutrient restriction on global methylation in fetal baboons. J Med Primatol (2009) 1.55

Chromatin: linking structure and function in the nucleolus. Chromosoma (2008) 1.14

Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects. Endocrinology (2012) 0.95

Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27. Mol Immunol (2010) 0.87

Size and number of tandem repeat arrays can determine somatic homologous pairing of transgene loci mediated by epigenetic modifications in Arabidopsis thaliana nuclei. Chromosoma (2008) 0.87

Is this the right normalization? A diagnostic tool for ChIP-seq normalization. BMC Bioinformatics (2015) 0.81

Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress. Brain Behav Immun (2010) 0.80

Pairing of lacO tandem repeats in Arabidopsis thaliana nuclei requires the presence of hypermethylated, large arrays at two chromosomal positions, but does not depend on H3-lysine-9-dimethylation. Chromosoma (2011) 0.80

3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models. BMC Pharmacol Toxicol (2013) 0.79

Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease. Neurobiol Aging (2015) 0.77

DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology. Epigenomics (2011) 0.76

An epigenetic toolkit allows for diverse genome architectures in eukaryotes. Curr Opin Genet Dev (2015) 0.76

Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression. Curr Genomics (2017) 0.75

A role for epigenetics in the formation of chromosome translocations in acute leukemia. Cancer Genet (2015) 0.75

Articles cited by this

Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell (1992) 27.80

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75

CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36

Cytosine methylation and the ecology of intragenomic parasites. Trends Genet (1997) 13.66

Epigenetic reprogramming in mammalian development. Science (2001) 13.42

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27

DNA methylation and human disease. Nat Rev Genet (2005) 12.00

Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat Rev Genet (2001) 11.70

The DNA methyltransferases of mammals. Hum Mol Genet (2000) 10.66

Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet (2004) 9.57

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (2002) 9.40

Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol (2003) 9.13

Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell (1992) 8.10

Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol (1998) 7.61

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature (1999) 6.42

Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol (1999) 6.35

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene (2002) 5.96

Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell (2004) 5.84

Nuclear structure in cancer cells. Nat Rev Cancer (2004) 5.12

Chromatin decondensation and nuclear reorganization of the HoxB locus upon induction of transcription. Genes Dev (2004) 5.11

DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet (2000) 5.09

The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum Mol Genet (2001) 4.79

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem (2002) 4.70

The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res (2003) 4.36

Three-dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes. PLoS Biol (2005) 4.33

DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev (2005) 4.25

Life at the edge: the nuclear envelope and human disease. Nat Rev Mol Cell Biol (2002) 3.84

The transcriptional role of PML and the nuclear body. Nat Cell Biol (2000) 3.80

Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev (1993) 3.64

Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol (1999) 3.49

Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J (2001) 3.36

Global chromosome positions are transmitted through mitosis in mammalian cells. Cell (2003) 3.27

Form follows function: The genomic organization of cellular differentiation. Genes Dev (2004) 3.20

Active RNA polymerases are localized within discrete transcription "factories' in human nuclei. J Cell Sci (1996) 3.16

How does DNA methylation repress transcription? Trends Genet (1997) 3.09

Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res (1992) 2.99

CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (2000) 2.94

Chromosome order in HeLa cells changes during mitosis and early G1, but is stably maintained during subsequent interphase stages. J Cell Biol (2003) 2.85

Chromosome methylation patterns during mammalian preimplantation development. Genes Dev (1998) 2.75

Erasure of CpG methylation in Arabidopsis alters patterns of histone H3 methylation in heterochromatin. Proc Natl Acad Sci U S A (2003) 2.70

Tissue-specific spatial organization of genomes. Genome Biol (2004) 2.57

Evolutionary conservation of chromosome territory arrangements in cell nuclei from higher primates. Proc Natl Acad Sci U S A (2002) 2.53

Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J (2002) 2.40

Spatial organization of chromosomes in the salivary gland nuclei of Drosophila melanogaster. J Cell Biol (1986) 2.39

Clustering of multiple specific genes and gene-rich R-bands around SC-35 domains: evidence for local euchromatic neighborhoods. J Cell Biol (2003) 2.38

Position-effect variegation and the genetic dissection of chromatin regulation in Drosophila. Semin Cell Dev Biol (2003) 2.37

Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol (2000) 2.36

Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol (2005) 2.34

Numbers and organization of RNA polymerases, nascent transcripts, and transcription units in HeLa nuclei. Mol Biol Cell (1998) 2.30

Concepts in nuclear architecture. Bioessays (2005) 2.19

Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei. J Cell Biol (2003) 2.12

Does looping and clustering in the nucleus regulate gene expression? Curr Opin Cell Biol (2004) 2.10

The function of nuclear architecture: a genetic approach. Annu Rev Genet (2004) 2.06

Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet (2002) 1.93

A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet (1998) 1.91

The radial positioning of chromatin is not inherited through mitosis but is established de novo in early G1. Curr Biol (2004) 1.85

Re-modelling of nuclear architecture in quiescent and senescent human fibroblasts. Curr Biol (2000) 1.84

Temporal and spatial coordination of chromosome movement, spindle formation, and nuclear envelope breakdown during prometaphase in Drosophila melanogaster embryos. J Cell Biol (1990) 1.80

Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol (2004) 1.74

Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem (2003) 1.71

Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem (2004) 1.64

Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol (2002) 1.58

The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity. J Biol Chem (2003) 1.46

The genome and the nucleus: a marriage made by evolution. Genome organisation and nuclear architecture. Chromosoma (2005) 1.45

Size-dependent positioning of human chromosomes in interphase nuclei. Biophys J (2000) 1.43

RNA-mediated interaction of Cajal bodies and U2 snRNA genes. J Cell Biol (2001) 1.41

Replication-dependent histone gene expression is related to Cajal body (CB) association but does not require sustained CB contact. Mol Biol Cell (2001) 1.38

Detection of snRNP assembly intermediates in Cajal bodies by fluorescence resonance energy transfer. J Cell Biol (2004) 1.35

Coiled bodies and U2 snRNA genes adjacent to coiled bodies are enriched in factors required for snRNA transcription. Mol Biol Cell (1998) 1.29

Chromatin organization in the mammalian nucleus. Int Rev Cytol (2005) 1.29

DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res (1999) 1.23

Spatial genome organization during T-cell differentiation. Cytogenet Genome Res (2004) 1.22

Mobility of multi-subunit complexes in the nucleus: accessibility and dynamics of chromatin subcompartments. Histochem Cell Biol (2005) 1.17

CpG-binding protein is a nuclear matrix- and euchromatin-associated protein localized to nuclear speckles containing human trithorax. Identification of nuclear matrix targeting signals. J Biol Chem (2002) 1.13

3D Structure of the human genome: order in randomness. Chromosoma (2002) 1.09

Alterations of DNA methylation patterns in germ cells and Sertoli cells from developing mouse testis. Cytogenet Cell Genet (1999) 1.05

Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis. Gut (2000) 1.04

The architecture of interphase chromosomes and gene positioning are altered by changes in DNA methylation and histone acetylation. J Cell Sci (2002) 1.03

New sites of methylcytosine-rich DNA detected on metaphase chromosomes. Hum Genet (1994) 0.91

DNA methylation and chromosome instability in lymphoblastoid cell lines. Cytogenet Cell Genet (2000) 0.88

Cytological evidence for 5-azacytidine-induced demethylation of the heterochromatic regions of human chromosomes. Chromosome Res (1996) 0.82

Distinct nuclear organization, DNA methylation pattern and cytokinin distribution mark juvenile, juvenile-like and adult vegetative apical meristems in peach (Prunus persica (L.) Batsch). J Exp Bot (2002) 0.80

Articles by these authors

Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature (2001) 4.99

Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res (1997) 4.73

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet (2001) 3.96

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 2.69

Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene (2011) 2.42

Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst (1999) 2.34

Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res (2001) 2.10

Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09

Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res (2000) 1.91

Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene (2008) 1.78

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene (2011) 1.76

Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. Cancer Res (1999) 1.69

CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene (2010) 1.65

Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res (2001) 1.63

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther (2009) 1.62

The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin Cancer Res (2013) 1.47

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene (1998) 1.36

Epigenetic regulation of telomeres in human cancer. Oncogene (2008) 1.33

Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene (2011) 1.31

Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer (2008) 1.27

The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis (2006) 1.25

NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. Cancer Prev Res (Phila) (2011) 1.21

Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene (2001) 1.17

The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res (2009) 1.16

Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin. Oncogene (2011) 1.13

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer (2007) 1.12

Specific hypermethylation of LINE-1 elements during abnormal overgrowth and differentiation of human placenta. Oncogene (2006) 1.11

Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol (2006) 1.10

Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res (2000) 1.10

Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins. Oncogene (2008) 1.07

Viral epigenomes in human tumorigenesis. Oncogene (2010) 1.06

5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut (2000) 1.04

Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res (2001) 0.98

Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation. Oncogene (2009) 0.97

Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res (1999) 0.97

Transforming pathways unleashed by a HDAC2 mutation in human cancer. Oncogene (2008) 0.93

Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet (2004) 0.90

Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events. J Cell Physiol (2007) 0.89

Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomas. Oncogene (2008) 0.88

Global DNA methylation: a common early event in oral cancer cases with exposure to environmental carcinogens or viral agents. P R Health Sci J (2009) 0.87

DNA methylation determines nucleosome occupancy in the 5'-CpG islands of tumor suppressor genes. Oncogene (2013) 0.86

Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leukemia (2005) 0.85

Merkel cell carcinoma of the vulva. Gynecol Oncol (1997) 0.83

Aberrant epigenetic landscape in intellectual disability. Prog Brain Res (2012) 0.81

Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. Oncogene (2009) 0.78

Towards defining the lymphoma methylome. Leukemia (2006) 0.78

Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene (2016) 0.78

Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer (2001) 0.76

Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas. Carcinogenesis (2005) 0.76

[Introduction to molecular biology of endometrial cancer]. Med Clin (Barc) (1996) 0.75

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia. Oncogene (2017) 0.75